The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial
Abstract
Background: Sepsis guidelines recommend daily review to de-escalate or stop antibiotics in appropriate patients. This randomized, controlled trial evaluated an opt-out protocol to decrease unnecessary antibiotics in patients with suspected sepsis. Methods: We evaluated non–intensive care adults on broad-spectrum antibiotics despite negative blood cultures at 10 US hospitals from September 2018 through May 2020. A 23-item safety check excluded patients with ongoing signs of systemic infection, concerning or inadequate microbiologic data, or high-risk conditions. Eligible patients were randomized to the opt-out protocol vs usual care. Primary outcome was post-enrollment antibacterial days of therapy (DOT). Clinicians caring for intervention patients were contacted to encourage antibiotic discontinuation using opt-out language. If continued, clinicians discussed the rationale for continuing antibiotics and de-escalation plans. To evaluate those with zero post-enrollment DOT, hurdle models provided 2 measures: odds ratio of antibiotic continuation and ratio of mean DOT among those who continued antibiotics. Results: Among 9606 patients screened, 767 (8%) were enrolled. Intervention patients had 32% lower odds of antibiotic continuation (79% vs 84%; odds ratio, 0.68; 95% confidence interval [CI], .47–.98). DOT among those who continued antibiotics were similar (ratio of means, 1.06; 95% CI, .88–1.26). Fewer intervention patients were exposed to extended-spectrum antibiotics (36% vs 44%). Common reasons for continuing antibiotics were treatment of localized infection (76%) and belief that stopping antibiotics was unsafe (31%). Thirty-day safety events were similar. Conclusions: An antibiotic opt-out protocol that targeted patients with suspected sepsis resulted in more antibiotic discontinuations, similar DOT when antibiotics were continued, and no evidence of harm. Clinical Trials Registration: NCT03517007.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized and stewardship studies similarly support reducing unnecessary exposure but do not suggest that de-escalation itself confers a survival benefit (6, 7).”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [6]
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Vincent, J.-L., & De Backer, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208943 · Cited by 1,425
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Fishman, N., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/665010 · Cited by 677
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397
Self-citationDesirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
Evans, S. R., Rubin, D., Follmann, D., Pennello, G., Huskins, W. C., Powers, J. H., Schoenfeld, D., Chuang-Stein, C., Cosgrove, S. E., Fowler, V. G., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ495 · Cited by 361
Tamma, P. D., Avdic, E., Keenan, J. F., Zhao, Y., Anand, G., Cooper, J., Dezube, R., Hsu, S., & Cosgrove, S. E. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw780 · Cited by 189
Handshake Stewardship: A Highly Effective Rounding-based Antimicrobial Optimization Service
Hurst, A. L., Child, J., Pearce, K., Palmer, C., Todd, J. K., & Parker, S. K. (2016) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001245 · Cited by 166
Accuracy of Practitioner Estimates of Probability of Diagnosis Before and After Testing
Morgan, D. J., Pineles, L. L., Owczarzak, J., Magder, L. S., Scherer, L. D., Brown, J., Pfeiffer, C., Terndrup, C., Leykum, L. K., Feldstein, D., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.0269 · Cited by 142
Cited by
Nelson, Z., Aslan, A. T., Beahm, N. P., Blyth, M. D., Cappiello, M., Casaus, D. V., Dominguez, F., Egbert, S., Hanretty, A. M., Khadem, T. M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.44495 · Cited by 136
Self-citationLópez-Cortés, L. E., Delgado-Valverde, M., Moreno-Mellado, E., Aguirre, J. G., Carrión, L. G., Vidal, M. J. B., Soria, L. M. L., Pérez-Rodríguez, M. T., Lamas, L. M., Revillas, F. A. D. L., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00686-2 · Cited by 50
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies
Singer, S., Kolodziej, L. E., Micek, S. T., & Kollef, M. H. (2025) · Antibiotics · doi:10.3390/antibiotics14050467 · Cited by 21
“More recently, a large randomized controlled trial conducted in patients with suspected sepsis in 10 United States hospitals assessed an “opt-out” protocol in which antibiotics would be discontinued after 48 to 96 h of blood culture negativity unless clinicians elected to opt out [32].”
Antibiotic De-escalation in adults hospitalized for community-onset Sepsis
Gupta, A. B., Heath, M., Walzl, E., Ratz, D., Munroe, E., Vaughn, V. M., Horowitz, J. K., Czilok, T., Petty, L. A., Gandhi, T. N., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.6919 · Cited by 14
Ahadinezhad, B., Maleki, A., Akhondi, A., Kazemi, M., Yousefy, S., Rezaei, F., & Khosravizadeh, O. (2024) · PLOS ONE · doi:10.1371/journal.pone.0290424 · Cited by 8
“A study exhibited that opt-out protocol resulted in harmless discontinuation of antibiotics in patients with suspected sepsis [66].”
BackgroundBug Wars: Artificial Intelligence Strikes Back in Sepsis Management
Barkas, G. I., Dimeas, I. E., & Kotsiou, O. S. (2025) · Diagnostics · doi:10.3390/diagnostics15151890 · Cited by 8
Kadri, S. S., Warner, S., Rhee, C., Klompas, M., Follmann, D. A., Swihart, B., Laxminarayan, R., & Klein, E. Y. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad286 · Cited by 5
Self-citationRapti, V., Poulakou, G., Mousouli, A., Kakasis, A., Pagoni, S., Pechlivanidou, E., Masgala, A., Sympardi, S., Apostolopoulos, V., Giannopoulos, C., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13090812 · Cited by 6
“The length of therapy was similar in both the intervention and the control group, albeit the exposure of patients in the rank-3 agent group (extended spectrum) was statistically lower in the intervention group [42].”
BackgroundA Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022
Barfield, R. K., Brown, M. L., Albrecht, B., Barber, K. E., Bouchard, J. L., Carr, A., Chahine, E. B., Cluck, D. B., Covington, E. W., Deri, C. R., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad687 · Cited by 4
“Moehring and colleagues conducted a multicenter, prospective, randomized, partially blinded, controlled trial to evaluate the impact of an opt-out protocol for antibiotic de-escalation versus standard of care in low-risk adults with suspected sepsis outside the intensive care unit (ICU) [18].”
BackgroundInfectious Diseases: What You May Have Missed in 2022
Ohaly, R. A., Benoit, M.-È., & Schuster, M. G. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0757 · Cited by 4
Risk factors for detection of Pseudomonas aeruginosa in clinical samples upon hospital admission
Reyle, R., Schwab, F., Saydan, S., Behnke, M., Leistner, R., Gastmeier, P., Geffers, C., & Kramer, T. S. (2025) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-025-01527-4 · Cited by 3
Significant Publications on Infectious Diseases Pharmacotherapy in 2022
Teran, N. S., Buckley, V., Britt, R. S., Ikwuagwu, J. O., Thomas, J. L., Zaki, A., Olson, K., Stramel, S., & on behalf of the Houston Infectious Diseases Network (2023) · Journal of Pharmacy Practice · doi:10.1177/08971900231194200 · Cited by 4
Manning, M. L., & Hou, C. M. (2024) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000821 · Cited by 2
Electronic Stewardship Prompts—Exploring the Why Behind the What
Hasegawa, S., & Livorsi, D. J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.12634 · Cited by 2
Altinger, G., Jones, C. M. P., Ferreira, G. E., Soon, J., Hoffmann, T., Maher, C. G., Chang, J. R., Linder, J. A., & Traeger, A. C. (2025) · BMJ Quality & Safety · doi:10.1136/bmjqs-2025-018793 · Cited by 2
Development of Inpatient Stewardship Metrics
Moehring, R. W., & Vaughn, V. M. (2023) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2023.07.006 · Cited by 1
Self-citationZhang, Y., Liao, G., Song, J., Liao, Y., & Zhang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1924203
“Randomized and stewardship studies similarly support reducing unnecessary exposure but do not suggest that de-escalation itself confers a survival benefit (6, 7).”
Han, W., Guo, H., Wang, Z., & Ding, R. (2024) · Research Square · doi:10.21203/rs.3.rs-3950858/v1
Pehlivanlı, A., Özgün, Ç., Sasal-Solmaz, F. G., Yüksel, D., Başgut, B., Ozcelikay, A. T., & Ünal, N. (2024) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2023-004053
Mahoney, M. V. G. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf708
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · RWTH Publications (RWTH Aachen) · doi:10.5167/uzh-280465
Cezard, P., Chocron, R., Laurenceau, T., Lahjibi‐Paulet, H., & Blez, D. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-06979-w
“This practice is, however, center dependent, and its safety has not been specifically addressed in elderly patients [16–18].”
Besen, B. A. M. P., Bianchini, L., Tomazini, B. M., Riera, R., de Toledo, I. P., & Colpani, V. (2026) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2026.10459
“Clinical pharmacists may act in collaboration with microbiologists, intensivists and ID physicians to improve delivery of many good practices, 25,36,37 such as watch-and-wait strategies, opt-out protocols for de-escalation, implementation of antibiotic time-outs for de-escalation or suspension of…”
Christensen, A. B., Cochran, G. L., Avedissian, S. N., Footer, B. W., Nelson, Z., Enzmann, M., & Peglow, S. R. (2026) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2026.10500
Mendoza, C., & Rahman, A. (2023) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/gygzsnkukd
Kim, D., Wright, E., & Moretti, L. (2024) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/qokj1cthtt
Metadata
- Authors
- Moehring, R. W., Yarrington, M. E., Warren, B. G., Lokhnygina, Y., Atkinson, E., Bankston, A., Collucio, J., David, M. Z., Davis, A. E., Davis, J., Dionne, B., Dyer, A. P., Jones, T. M., Klompas, M., Kubiak, D. W., Marsalis, J., Omorogbe, J., Orajaka, P., Parish, A., Parker, T., Pearson, J. C., Pearson, T., Sarubbi, C., Shaw, C., Spivey, J., Wolf, R., Wrenn, R. H., Dodds Ashley, E. S., Anderson, D. J., & Program, T. C. F. D. C. A. P. P. E.
- Affiliations
- Duke University (US)
- Southeastern Health (US)
- Piedmont Newnan Hospital (US)
- Department of Pharmacy, Piedmont Atlanta Hospital , Atlanta, Georgia , USA
- University of Pennsylvania (US)
- Department of Pharmacy, Piedmont Fayette Hospital , Fayette, Georgia , USA
- Brigham and Women's Hospital (US)
- Department of Pharmacy, Iredell Health , Statesville, North Carolina , USA
- Piedmont Atlanta Hospital (US)
- Rex Hospital (US)
- Department of Pharmacy, Wilson Medical Center , Wilson, North Carolina , USA
- Department of Medicine, Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention , Durham, North Carolina , USA
- Corresponding author
- Moehring, Rebekah W
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-09-28
- Volume
- 76
- Issue
- 3
- Pages
- 433-442
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4297460649
- Cited by
- 27
- References
- 25
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 9 · 2023: 5
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Keywords
- antibiotic de-escalation, suspected sepsis, antibiotic discontinuation, days of therapy, broad-spectrum antibiotics, negative blood cultures, antibiotic stewardship, provider communication
- MeSH terms
- Adult, Anti-Bacterial Agents, Humans, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.